Amgen Inc Stock In The News
| AMGN Stock | USD 313.71 1.07 0.34% |
Our overall analysis of Amgen's news coverage and content from conventional and social sources shows investors' bearish mood towards Amgen Inc. The specific impact of Amgen news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Amgen's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Amgen headlines in addition to utilizing other, more conventional financial analysis modules. Check out Amgen Backtesting and Amgen Hype Analysis.
Amgen |
Amgen Today Top News and Investor Outlook
Amgen Inc Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Amgen and other traded companies coverage with news coverage. We help investors stay connected with Amgen headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Amgen Stock performance. Please note that trading solely based on the Amgen Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
Amgen stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Amgen earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Amgen that are available to investors today. That information is available publicly through Amgen media outlets and privately through word of mouth or via Amgen internal channels. However, regardless of the origin, that massive amount of Amgen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amgen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amgen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amgen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amgen alpha.
Amgen Largest EPS Surprises
Earnings surprises can significantly impact Amgen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
1998-07-22 | 1998-06-30 | 0.18 | 0.21 | 0.03 | 16 | ||
1999-10-20 | 1999-09-30 | 0.24 | 0.28 | 0.04 | 16 | ||
2006-07-20 | 2006-06-30 | 0.94 | 1.05 | 0.11 | 11 | ||
2008-07-28 | 2008-06-30 | 1.02 | 1.14 | 0.12 | 11 | ||
2009-07-27 | 2009-06-30 | 1.16 | 1.29 | 0.13 | 11 | ||
2008-10-22 | 2008-09-30 | 1.08 | 1.23 | 0.15 | 13 |
Amgen Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Amgen Inc Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
12th of March 2025
Amgens Options A Look at What the Big Money is Thinking at benzinga.com
11th of March 2025
HALO vs. AMGN Which Stock Is the Better Value Option at zacks.com
10th of March 2025
Novo Nordisks Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss at medcitynews.com
7th of March 2025
Dividend Roundup Nvidia, Amgen, Home Depot, JD.com, and more at seekingalpha.com
6th of March 2025
2 Reasons to Watch AMGN and 1 to Stay Cautious at finance.yahoo.com
4th of March 2025
AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND at finance.yahoo.com
28th of February 2025
Amgen Inc to Present at 45th Annual TD Cowen Health Care Conference at gurufocus.com
24th of February 2025
Is Amgen Inc. One of the Best Performing Dow Stocks So Far in 2025 at insidermonkey.com
Amgen Investors Sentiment
The influence of Amgen's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Amgen. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Amgen's public news can be used to forecast risks associated with an investment in Amgen. The trend in average sentiment can be used to explain how an investor holding Amgen can time the market purely based on public headlines and social activities around Amgen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amgen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amgen's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Amgen's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Amgen.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amgen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amgen's short interest history, or implied volatility extrapolated from Amgen options trading.
Check out Amgen Backtesting and Amgen Hype Analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.19) | Dividend Share 9 | Earnings Share 7.56 | Revenue Per Share | Quarterly Revenue Growth 0.109 |
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.